M&T Bank
KERX

M&T Bank’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

M&T Bank’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-18,501
Closed -$185K – 2118
2015
Q2 		$185K Sell
18,501
-2,442
-12% -$26.2K ﹤0.01% 1800
2015
Q1 		$267K Sell
20,943
-421
-2% -$5.41K ﹤0.01% 1537
2014
Q4 		$303K Sell
21,364
-7,938
-27% -$123K ﹤0.01% 1476
2014
Q3 		$403K Buy
+29,302
New +$449K ﹤0.01% 1383

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

M&T Bank's KERX Position: Q3 2015 in Review

M&T Bank sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2015, closing a stake of 18,501 shares — an estimated $185K sold.

M&T Bank first reported a position in KERX in Q3 2014 and held it in 4 quarters. The position peaked at $403K in Q3 2014. 138 funds tracked by Wall St. Rank hold KERX as of Q3 2015.

  • M&T Bank reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • M&T Bank sold 18,501 Keryx Biopharmaceuticals Inc shares in Q3 2015, an estimated $185K.
  • M&T Bank first reported a position in Keryx Biopharmaceuticals Inc in Q3 2014 and held it in 4 quarters.
  • M&T Bank's Keryx Biopharmaceuticals Inc position peaked at $403K in Q3 2014.
  • 138 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.